Form 4 for SPRO Spero Therapeutics, Inc.
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-27 · accession 0000950170-24-101998 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-29 | 2024-08-27 | SPRO | Keutzer Timothy | COO | S - Sale | $1.35 | -2,213 | 531.8K | -0.4% | -$2,988 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-27 | S | D | 2,213 | $1.35 | 531,837 | D | — | — |